| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab
|
Villaescusa, Lucinda
|
|
|
39 |
3 |
p. 1126-1148
|
artikel
|
| 2 |
Assessment of the Cost-Effectiveness of HER2-Targeted Treatment Pathways in the Neoadjuvant Treatment of High-Risk HER2-Positive Early-Stage Breast Cancer
|
Sussell, Jesse A.
|
|
|
39 |
3 |
p. 1375-1392
|
artikel
|
| 3 |
Biosimilar Pegfilgrastim-cbqv Demonstrated Similar Immunogenicity to Pegfilgrastim in Healthy Subjects Across Three Randomized Clinical Studies
|
Civoli, Francesca
|
|
|
39 |
3 |
p. 1230-1246
|
artikel
|
| 4 |
Budget Impact Analysis of Impella CP® Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis
|
Delmas, Clément
|
|
|
39 |
3 |
p. 1293-1309
|
artikel
|
| 5 |
Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
|
Breccia, Massimo
|
|
|
39 |
3 |
p. 1101-1106
|
artikel
|
| 6 |
Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
|
Tabberer, Maggie
|
|
|
39 |
3 |
p. 1446
|
artikel
|
| 7 |
Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort
|
Pollock, Carol
|
|
|
39 |
3 |
p. 1432-1445
|
artikel
|
| 8 |
Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
|
Vareesangthip, Kriengsak
|
|
|
39 |
3 |
p. 1279-1292
|
artikel
|
| 9 |
Disease Activity-Guided Stepwise Tapering but Not Discontinuation of Biologics Is a Feasible Therapeutic Strategy for Patients with Ankylosing Spondylitis: Real-World Evidence
|
Ye, Lingying
|
|
|
39 |
3 |
p. 1393-1402
|
artikel
|
| 10 |
Early Changes and Predictive Value of Serum Histone H3 Concentration in Urosepsis: A Prospective Observational Study
|
Zhan, Xiangcheng
|
|
|
39 |
3 |
p. 1310-1323
|
artikel
|
| 11 |
Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review
|
Sallum, Juliana M. F.
|
|
|
39 |
3 |
p. 1179-1198
|
artikel
|
| 12 |
Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients in the United States Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines: A Retrospective Cohort Study
|
Amari, Diana T.
|
|
|
39 |
3 |
p. 1324-1340
|
artikel
|
| 13 |
How to Choose the Right Inhaler Using a Patient-Centric Approach?
|
Cataldo, Didier
|
|
|
39 |
3 |
p. 1149-1163
|
artikel
|
| 14 |
Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation
|
De Lucia, Orazio
|
|
|
39 |
3 |
p. 1267-1278
|
artikel
|
| 15 |
Impact of Social Determinants on the Burden of Asthma and Eczema: Results from a US Patient Survey
|
Bukstein, Don A.
|
|
|
39 |
3 |
p. 1341-1358
|
artikel
|
| 16 |
Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
|
Nakazawa, Toru
|
|
|
39 |
3 |
p. 1359-1374
|
artikel
|
| 17 |
iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control
|
Hengerer, Fritz H.
|
|
|
39 |
3 |
p. 1417-1431
|
artikel
|
| 18 |
Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany
|
Steinmetz, H. Tilman
|
|
|
39 |
3 |
p. 1247-1266
|
artikel
|
| 19 |
Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
|
Kato, Aki
|
|
|
39 |
3 |
p. 1403-1416
|
artikel
|
| 20 |
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
|
Villani, Alessia
|
|
|
39 |
3 |
p. 1164-1178
|
artikel
|
| 21 |
Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs
|
Patel, Charmi
|
|
|
39 |
3 |
p. 1199-1214
|
artikel
|
| 22 |
Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France
|
Roset, Montserrat
|
|
|
39 |
3 |
p. 1215-1229
|
artikel
|
| 23 |
Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
|
Fontes-Sousa, Mário
|
|
|
39 |
3 |
p. 1107-1125
|
artikel
|
Tijdschrift beschrijving